What Pentavere does

Pentavere Research Group Inc., founded in 2016 and headquartered in Toronto, is a healthcare AI company that builds and commercializes DARWEN AI, a proprietary clinical natural language processing engine designed to extract structured data from unstructured electronic health records (EHRs), including consult notes, radiology reports, pathology reports, and clinical narratives. The technology combines linguistic rules-based algorithms, transformer-based models, deep learning, and machine-learned inferred rules, and is trained on a proprietary corpus of over 100,000 patients with an average of 50 clinical notes per patient; DARWEN supports contextual disambiguation such as negation, hypothesis, and experiencer, and has been validated in peer-reviewed publications reporting accuracy above 90% on complex clinical features across oncology, tuberculosis, dermatology, and rare disease cohorts.

DARWEN powers a portfolio of specialized applications rather than a single product, including a Breast Cancer Data and Analytics Platform (7,019 patients, 141 data elements), a Cancer Staging Clinician Co-pilot developed with Sunnybrook, a Radiation-Related Late Toxicities detection module, a Heart Failure Patient Identification & Optimization Program, and rare disease real-world evidence (RWE) services such as the Takeda hereditary angioedema program. The company also offers Clinical Decision Support, RWE & Advanced Analytics, and Data Enrichment and Structuring services.

Pentavere operates as a B2B enterprise with a direct field-sales motion, selling to two primary customer segments: global pharmaceutical companies (it states it works with 6 of the top-10 largest pharma, with disclosed logos including Takeda, Janssen/Johnson & Johnson, Roche, Amgen, and UCB) and healthcare providers/cancer centers (including University Health Network/Princess Margaret, Sunnybrook, Unity Health, St. Michael's, Juravinski, and St. Boniface). Revenue is generated through subscription/recurring enterprise agreements and project-based services, pricing is quote-based and not publicly disclosed, and the company holds ISO 9001, ISO/IEC 27001, and SOC 2 certifications. Pentavere is a subsidiary of HEALWELL AI Inc. (TSX: AIDX), consolidated within its AI & Data Science Business Unit alongside Khure Health, and the company has won the Prix Galien USA 2024 Best Digital Health Startup award.

Name

Pentavere

Legal name

Pentavere Research Group Inc.

Website

https://pentavere.ai

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Pentavere is a Toronto-based healthcare AI company that builds DARWEN AI, a proprietary clinical NLP engine which extracts structured data from unstructured EHR text to identify eligible patients and generate real-world evidence for global pharmaceutical companies and major hospital systems.

Ownership category

akta.pro rank

Product category

Healthcare AI / Clinical Natural Language Processing Software

NAICS

Software Publishers (5132)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs) (HDAEANAJ)

akta.pro secondary industries

Electronic Data Capture (EDC) Platforms (HLACAOAA), Generative AI & LLM Solutions Services (RAG, Agents, Copilots) (BPAEAHAG)

Keywords

• Clinical natural language processing
• Healthcare AI platform
• Electronic health records analytics
• Real-world evidence generation
• Patient identification analytics

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Healthcare AI/SaaS Services: Pentavere generates revenue through enterprise agreements with healthcare systems, hospitals, and life sciences companies for AI-powered data extraction, patient identification, and real-world evidence generation services. The company operates as a B2B SaaS and services model, providing technology solutions to healthcare providers and pharmaceutical companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Pentavere builds and operates DARWEN™ AI, a proprietary clinical natural language processing engine that extracts structured patient and clinical data from unstructured electronic health record text. The company sells enterprise AI solutions — patient identification programs (e.g., heart failure), real-world evidence analytics, clinical decision support, and data enrichment services — to healthcare providers, hospital systems, and global pharmaceutical companies.

Product overview

Pentavere is a Patient Identification Company that has built DARWEN™ AI, a best-in-class AI engine to identify patients eligible for approved medications or interventions to improve outcomes. The company's offering centers on a unified AI platform that combines NLP, machine learning, and deep learning (including transformer-based models) to extract structured clinical data from unstructured hospital EHRs. The core DARWEN™ AI platform powers multiple specialized applications including patient identification programs (Heart Failure), clinical decision support tools (Cancer Staging Clinician Co-pilot), disease detection capabilities (Radiation-Related Toxicities), and real-world evidence generation services. The company also delivers complementary services including Clinical Decision Support (CDS), Real-World Evidence & Advanced Analytics, and Data Enrichment and Structuring Services. Pentavere operates as a subsidiary of HEALWELL AI within the AI & Data Science Business Unit alongside Khure Health.

Differentiator

Problem solved

Functional benefit

Brands

• DARWEN™ AI: Pentavere's proprietary AI engine that identifies patients eligible for approved medications or interventions, accelerates discovery from clinical text, and unlocks real-world evidence from unstructured hospital electronic medical records.

Products and services

• DARWEN™ AI Pentavere's flagship AI engine that identifies patients eligible for approved medications or interventions by processing unstructured hospital EHR data. Combines NLP (linguistic rules-based algorithms, deep learning, and transformer-based models) with machine learning to extract, structure, and analyze clinical data at scale, enabling real-world evidence generation and clinical decision support.
• Heart Failure Patient Identification & Optimization Program A specialized DARWEN AI-powered program that identifies heart failure patients who may be eligible for different medications or interventions to improve patient outcomes.
• Cancer Staging Clinician Co-pilot System An AI-powered clinical decision support system developed with Sunnybrook that assists clinicians in improving cancer staging accuracy.
• Radiation-Related Toxicities Detection DARWEN AI capability that identifies radiation-related late toxicities including dysphagia, fibrosis, osteoradionecrosis, and trismus from head and neck cancer patient EHRs.
• Breast Cancer Data and Analytics Platform An automated longitudinal prospective data and analytics platform for breast cancer at regional cancer centers, combining data warehousing with NLP to deliver integrated, timely, high-quality data for learning health system activities.
• Rare Disease Real-World Evidence Analysis DARWEN AI-powered service that analyzes clinical data to generate real-world evidence for rare disease patient populations, exemplified by hereditary angioedema (HAE) and idiopathic angioedema research.
• Clinical Decision Support (CDS) AI-enabled tools integrated with EMR systems that analyze patient data to identify patients at risk of rare or complex diseases, surface guideline-based insights, support risk stratification, and highlight potential clinical trial eligibility.
• Real-World Evidence & Advanced Analytics Data extraction, NLP, and analytics platforms that transform structured and unstructured clinical data, identify patient cohorts, generate population-level insights, support REB-approved studies, and produce real-world evidence outputs for quality improvement and health system reporting.
• Data Enrichment and Structuring Services Solutions that convert raw or unstructured PHI into structured formats, perform data standardization and validation, and support clinical operations and research analytics.

Quantifiable outcome

• NLP achieved accuracy of 96% for simple features, 93% for moderate complexity features, and 91% for complex features in TB clinic study (Journal of Medical Internet Research)
• +4 more outcomes

Named customers12 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Canada Health InfowaycoreStrategic or Co-development Partner · 28 May 2025Pentavere (along with Intrahealth and OceanMD, other WELL Health subsidiaries) was selected for Canada Health Infoway's 2025 Vendor Innovation Program. The project focuses on improving healthcare data interoperability through AI-powered tools and standardized FHIR-based systems, to be deployed in live clinical environments across five Canadian provinces.
• Takeda CanadacoreStrategic or Co-development Partner · 6 June 2024Partnership to support rare disease real-world evidence analysis for patients living with hereditary angioedema (HAE). Pentavere's AI technology extracts clinical data to analyze patient outcomes, treatment patterns, and healthcare utilization for this rare condition.
• Sunnybrook Health Sciences CentrecoreStrategic or Co-development Partner · 21 May 2024Partnership to demonstrate that Pentavere's AI-powered clinician co-pilot system can improve cancer staging. The collaboration resulted in a peer-reviewed publication demonstrating the technology's effectiveness in supporting clinical decision-making.
• Takeda CanadacoreStrategic or Co-development Partner · 11 May 2022Pentavere was awarded the Takeda Canada Innovation Challenge to collaborate on a proof-of-concept AI project focused on rare disease care. The partnership involves using Pentavere's DARWEN AI technology to generate real-world evidence for rare disease patients across Canada, with dedicated funding and access to Takeda's expertise and international network.
• HEALWELL AIcoreOthersPentavere Research Group Inc. is a subsidiary of HEALWELL AI Inc. (TSX: AIDX, OTCQX: HWAIF), a healthcare technology company focused on AI and data science for preventative care. HEALWELL consolidates Pentavere and Khure Health under its AI & Data Science business unit.
• Journal of Clinical OncologyminorGTM or Marketing PartnerAcademic publication partnership validating DARWEN AI technology for automated data extraction from EHRs. Published studies demonstrate technology accuracy and clinical applicability for generating real-world evidence.
• Princess Margaret Cancer Centre (UHN)coreStrategic or Co-development PartnerLong-standing collaboration for extracting and analyzing lung cancer patient data using DARWEN AI. The partnership enables querying of clinical data to understand treatment patterns, real-world outcomes, and support research initiatives.

Scale indicators1 record

Recent moves6 records

Expansion highlights6 records

Direct peers

• Datavant: Datavant connects and de-identifies real-world patient data across providers and life sciences customers for research and analytics. It is a peer in the health data connectivity and RWE value chain that Pentavere serves through DARWEN.
• Tempus Labs: Tempus applies AI to clinical and molecular data to enable precision medicine, with direct applications in oncology patient identification and RWE generation. It competes with Pentavere in AI-driven EHR data structuring for pharma and providers.
• Verana Health: Verana Health curates real-world clinical data from specialty EHR networks to support pharma research and physician decision-making. It is directly comparable to Pentavere's DARWEN-based approach of extracting structured insights from unstructured EHR data for life sciences customers.
• TriNetX: TriNetX operates a global health research network that leverages EHR data for clinical trial feasibility and real-world studies. It overlaps with Pentavere's patient identification and clinical research use cases for pharma customers.
• nference: nference applies NLP and AI to biomedical and clinical text to generate real-world evidence for pharma and providers. Its technology stack and target customer base closely mirror Pentavere's DARWEN AI engine and life sciences partnerships.
• Flatiron Health: Flatiron Health builds EHR-derived real-world datasets, primarily in oncology, and partners with pharma for RWE and clinical research. It is the closest direct peer to Pentavere, working with leading cancer centers and pharma on structured data extraction from unstructured clinical text.
• Aetion: Aetion provides a real-world evidence analytics platform used by top pharma companies and regulators for treatment effectiveness and safety studies. It overlaps with Pentavere's RWE offering for pharma customers and competes for similar enterprise contracts.

Emerging players

• Owkin: Owkin applies AI to clinical and omics data to support pharma R&D and patient stratification, with a growing focus on oncology. It is an emerging player competing for similar pharma AI and real-world data budgets as Pentavere.

Broad incumbents

• IQVIA: IQVIA is the largest contract research and real-world evidence company, offering technology platforms for clinical data extraction and RWE generation serving the same top-10 pharma customer base as Pentavere. It is a broad incumbent covering the same enterprise pharma and provider use cases at much greater scale.
• Medidata (Dassault Systèmes): Medidata is a leading clinical trial technology platform offering EDC, RWE, and analytics for life sciences sponsors. As a broad incumbent in clinical research informatics, it overlaps with the EDC and RWE use cases Pentavere targets with DARWEN.

Market position

Strengths5 records

Weaknesses3 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pentavere

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pentavere